Hospital de Clinicas de Porto Alegre - HCPA

Porto Alegre 90035-903

2 studies enrolling now · 6 studies all time

What they study most

Advanced Melanoma, Gaucher Disease, Type 1, Menopausal Symptoms, PD-L1 Negative, Primary Biliary Cholangitis (PBC), Triple Negative Breast Cancer, Vasomotor Symptoms

Studies at this site

• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis — Recruiting now
• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• A Gene Therapy Study in Patients With Gaucher Disease Type 1 — Completed
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2) — Running, not enrolling
• Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) — Completed